Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.52 EUR | +3.68% | +7.15% | -4.54% |
Apr. 24 | COVIVIO : Invest Securities remains Buy after sales release | CF |
Apr. 24 | Covivio: stable revenues in Q1 | CF |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 82% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The company has a low valuation given the cash flows generated by its activity.
- The company is one of the best yield companies with high dividend expectations.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- One of the major weak points of the company is its financial situation.
- With an expected P/E ratio at 47.05 and 9.34 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Commercial REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-4.54% | 4.98B | - | ||
-6.46% | 46.25B | A- | ||
-8.31% | 20.33B | A- | ||
-3.56% | 13.07B | A- | ||
+16.05% | 11.53B | A | ||
-4.85% | 9.68B | B+ | ||
-0.83% | 8.48B | A- | ||
-14.19% | 8.38B | B- | ||
+1.38% | 7.63B | A- | ||
-18.42% | 5.53B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- COV Stock
- 0J6V Stock
- Ratings Covivio